Dec-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
Vireo's performance in the cannabis market showcases interesting trends, especially when examining their presence across different states and product categories. In the state of New York, Vireo's presence in the Concentrates category experienced a notable absence from the top 30 rankings throughout the last quarter of 2025. This absence indicates a potential area for growth or a need for strategic reevaluation, as being outside the top 30 suggests limited market penetration or competition challenges in that specific category. Despite this, Vireo's sales in New York for December 2025 were recorded at $10,678, which could imply some underlying demand or niche market presence that might be leveraged for future growth.
While Vireo's performance in New York's Concentrates category hints at challenges, it's crucial to consider their broader market strategies and performance in other states and categories, which could paint a more comprehensive picture of their brand trajectory. The absence of ranking data in other states or categories suggests that Vireo has yet to establish a significant footprint or competitive edge outside of New York, or perhaps they are focusing their efforts on niche markets not captured in the top 30 rankings. This strategic focus might mean they are prioritizing depth over breadth, potentially honing in on specific consumer bases or innovating within particular product lines. Observing how Vireo navigates these dynamics in the coming months could provide valuable insights into their market strategy and growth potential.
Competitive Landscape
In the New York concentrates market, Vireo experienced a notable shift in its competitive positioning by December 2025, ranking 40th, having not appeared in the top 20 in previous months. This indicates a challenging competitive landscape, especially when compared to brands like Jaunty, which maintained a strong presence with a 5th place rank in September 2025. Meanwhile, Happy Cabbage Farms and Revival both saw fluctuations, with Happy Cabbage Farms dropping out of the top 20 by October and Revival entering at 36th in November and slightly declining to 38th in December. Head & Heal also re-entered the top 40 in December, ranking 36th. These dynamics suggest that while Vireo is re-establishing its presence, it faces stiff competition from brands that have either maintained or improved their market positions, highlighting the need for strategic adjustments to enhance its competitive edge and sales performance.

Notable Products
In December 2025, the top-performing product for Vireo was the CBD/THC 1:1 Alfonso Mango Gummie (100mg CBD, 100mg THC) in the Edible category, which rose to the number one rank with impressive sales of 137 units. The Sativa RSO Syringe (1g) in the Concentrates category climbed to the second position, showing a notable improvement from its third rank in November. The CBD/THC 1:19 Red Balm (5mg CBD, 95mg THC, 1.5oz) maintained a steady presence in the top three, ranking third in December. The Hybrid RSO Syringe (1g), also in the Concentrates category, slipped from its top position in November to fourth place in December. Finally, the CBD/THC 1:1 Green Balm (25mg CBD, 25mg THC) entered the rankings for the first time in December, securing the fifth spot.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.







